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Fbxo30 is an orphan member of the F-box protein
family with no known substrate or function. Here
we report that, while Fbxo30/ mice exhibit normal
development, growth, lifespan, and fertility, the
females fail to nurture their offspring as a result of
defective mammopoiesis. Mass spectrometry anal-
ysis of Fbxo30-associated proteins revealed that
Fbxo30 specifically interacts with the bipolar spindle
kinesin EG5 (encoded by Kif11). As a result, Fbxo30
targets Eg5 for ubiquitinylation and controls its
oscillation during the cell cycle. Correlated with EG5
dysregulation, Fbxo30/ mammary epithelial cells
exhibit multiple defects in centrosome homeostasis,
mitotic spindle formation, and proliferation. Effects
on proliferation, centrosome homeostasis, and
mammopoiesis in the Fbxo30/ mice were rescued
through normalization of Eg5 activity using shRNA
and/or an EG5 inhibitor. Our data reveal the Fbxo30-
Eg5 interactionasacritical checkpoint inmammopoi-
esis and a critical role for ubiquitinylation-regulated
Eg5 oscillation in the cell cycle.
INTRODUCTION
F-box proteins (FBXs) are defined by the shared protein-protein
interaction domain called F-box. Based on the existence of addi-
tional structural motifs, FBXs are divided into three subfamilies,
including FBXW (for the WD40 domain), FBXL (for leucine-rich
motif), and FBXO (for other motifs) (Jin et al., 2004). FBXs often
interact with a specific motif on the substrate called degron.
Since the interactions between the best-characterized FBXs
and their substrates are regulated by phosphorylation of the de-
gron (Ko˜ivoma¨gi et al., 2011; Liu et al., 2002; Nash et al., 2001;
Wei et al., 2005), the term phosphodegron was coined to epito-
mize regulation between FBXs and their substrates (Skaar et al.,
2013). However, it is increasingly clear that many FBX-substrate
interactions are either based on recognition of the unmodified
degron sequence (D’Angiolella et al., 2010, 2012) or recognition
of degronwith other covalentmodification, such as glycosylationC
This is an open access article under the CC BY-N(Yoshida et al., 2002). More recently, phosphorylation of degron
has been shown to inhibit FBXL12 binding to p85b subunit of
PI3K (Kuchay et al., 2013).
The biological function of FBX is informed by their specific
substrates. By conferring substrate specificity to the SCF ubiq-
uitin E3 ligases, FBXs regulate a variety of cellular functions,
including the cell cycle (Carrano et al., 1999; Frescas and Pa-
gano, 2008), signal transduction (Ko˜ivoma¨gi et al., 2011; Kuchay
et al., 2013; Liu et al., 2002; Nash et al., 2001; Wei et al., 2005),
DNA repair (D’Angiolella et al., 2012), and genomic instability
(Puklowski et al., 2011), among others (Skaar et al., 2013).
Despite the extensive effort, the substrates for the majority of
FBXs remain to be identified. This gap prevents us from fully un-
derstanding the function and mechanism of action of FBX. Iden-
tification of the substrates for the orphan FBX is a major focus in
cell biology, as these efforts not only clarify the function of the
orphan FBXs but also elucidate, to our knowledge, novel cellular
regulatory pathways.
FBXO30 is an orphan FBX with no known substrates. Here, we
take a reverse genetic approach to evaluate the function of
Fbxo30 in mice. Our data revealed an unexpected function of
the Fbxo30 gene in mammopoiesis, including branch morpho-
genesis and defective production of mature luminal epithelial
cells. Mass spectrometry analysis of Fbxo30-associated pro-
teins revealed motor protein Eg5 as Fbxo30 substrate. By regu-
lating Eg5 abundance, Fbxo30 regulates mitosis and mammo-
poiesis. Our data not only revealed an unexpected function of
Fbxo30 in organogenesis but also identified it as a critical regu-
lator for mitosis.
With identification of mammary stem cells (Shackleton et al.,
2006; Stingl et al., 2006), the mouse has emerged as a major
tool to study mammopoiesis. Accumulating data led to a devel-
opmental pathway for differentiation of mammary stem cells into
progenitors for basal myoepithelial and luminal epithelial cells,
respectively (Shackleton et al., 2006; Stingl et al., 2006; Visvader,
2009; Visvader and Stingl, 2014). Genetic studies indicate critical
roles for Slug and Sox9 as key determinants of mammary stem
cell function (Guo et al., 2012). Commitment to a luminal fate
versus a basal fate is influenced by the expression of p63 and
Notch 1 and Notch 3, respectively (Bouras et al., 2008; Raouf
et al., 2008; Yalcin-Ozuysal et al., 2010). Elf5 has emerged as a
key in specifying luminal fate (Chakrabarti et al., 2012; Oakes
et al., 2008), while GATA3 directs differentiation to luminalell Reports 15, 1111–1122, May 3, 2016 ª2016 The Authors 1111
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
epithelial cells (Asselin-Labat et al., 2007). Our data presented
herein reveal a critical role for Fbxo30-EG5 interaction mammary
gland morphogenesis and, thus, suggest a critical checkpoint in
mammopoiesis.
RESULTS
Mice with Targeted Mutations of Fbxo30 Reveal a
Critical Role for Fbxo30 in Mouse Mammopoiesis
With the exception of a small stretch of 68 amino acids (aa) en-
coded by exon 3, the majority of the 746 aa of Fbxo30 are en-
coded by exon 2. We replaced the 3.5 kb genomic DNA encom-
passing the entire region of exon 2 (2.1 kb) and part of intron 2
(1.4 kb) with an in-frame GFP cDNA followed by a Neomycin
cassette for selection (Figure S1). The heterozygous mutant
embryonic stem cells (ESCs) of C57BL/6 origin were used to
generate chimeric mice. The null allele was germline-trans-
mitted at a Mendelian ratio, suggesting that the Fbxo30
gene was not essential for mouse development. Moreover,
Fbxo30/ and Fbxo30+/+ littermates had normal fertility and
grew at a similar rate with indistinguishable lifespan. Surpris-
ingly, regardless of the paternal genotypes, mutation of the
Fbxo30 in the nursing female reduced the survival of the
offspring, as the survival rates of offspring from Fbxo30/,
Fbxo30+/, and Fbxo30+/+ females were 0%–12%, 55%–69%,
and 82%–84%, respectively (Table S1). Only a small number
of offspring were successfully nurtured by Fbxo30/mice, usu-
ally after multiple pregnancies.
Since the offspring of Fbxo30/ females developed normally
with foster mothers and since necropsy revealed that the pups
died of starvation (data not shown), we examined the mammary
glands by histology and flow cytometry. In mammary gland
whole mounts, virgin Fbxo30/ mice had atrophic mammary
glands, characterized by both reduced branching and atrophic
large ducts (images in Figure 1A). The ratio between lateral
branches and large ducts was decreased by Fbxo30 deletion
(Figure 1A, right panel). Pregnancy of wild-type (WT) mice is
associated with increased branching and formation of alveolar
structures in the branches. However, the Fbxo30/ mammary
glands showed diminished branching with the alveoli forming
adjacent to the large ducts (Figure 1B). Histological analysis
revealed that, while WT mammary glands had proliferated
massively at day 2 postpartum, those in Fbxo3/ mice re-
mained largely atrophic (Figure 4C). Furthermore, while most of
the glandules in Fbxo30+/+ mice were filled with milk droplets,
very few glandules in the Fbxo30/ mice contained milk drop-
lets. These findings explained why the Fbxo30/ female failed
to nurture the offspring.
To identify the relative number of luminal epithelial versus my-
oepithelial cells, we stained mammary sections with antibodies
specific for cytokeratin (CK) 8 (luminal epithelial cells) or CK5
(basal myoepithelial cells). A reduction in the ratio of CK8+/
CK5+cells was observed in the Fbxo30/mammary glands (Fig-
ure 1D). The normal development of myoepithelial cells was
confirmed by using a panel of different markers, including
CK14, CK17, and aSMA (Figure 1E). Remarkably, production
of mucin by the luminal epithelial cells was largely abrogated
by Fbxo30 deletion (Figure 1E).1112 Cell Reports 15, 1111–1122, May 3, 2016We analyzed the cellular composition of the mammary glands
using CD29, CD49f, CD61, and CD24 markers (Visvader, 2009).
CD45 and CD31 were used to mark hematopoietic cells and
vascular endothelial cells, respectively, for exclusion. We used
flow cytometry to characterize the frequency of major cell types
in the mammary gland. Representative fluorescence-activated
cell sorting (FACS) profiles are shown in Figure 2A, while sum-
mary data of the major mammary gland cell types are shown in
Figures 2B and 2C. Among the CD45CD31 cells, we observed
a reduction in the proportion of CD24+CD29lo cells (Figure 2A,
upper panels). Since essentially all of the CD24+CD29lo cells ex-
pressed high levels of CD49f (Figure 2A, lower panels), they be-
longed to luminal epithelial cells. Conversely, the percentage of
CD24+CD29hiCD49+ myoepithelial cells was increased (Fig-
ure 2A). In combination, the increase of myoepithelial and
decrease of luminal epithelial cells resulted in a nearly 2-fold
decrease in the relative abundance of luminal lineages (Fig-
ure 2B). Correspondingly, the absolute numbers of luminal
epithelial cells recovered from the Fbxo30/was more severely
reduced (Figure 2C).
We used the accepted CD31CD45CD24hiCD29hiSca1
markers to assess the amounts of mammary stem cells in WT
and Fbxo30/mice. Among CD45CD31 cells frommammary
glands, a reduction of the CD24hiCD29fhi cells was observed in
the Fbxo30/ mammary gland, as demonstrated in Figure 3A
(left panels). However, the CD49fhiSca-1 populations were
reduced in the Fbxo30/ mammary gland. As a result, the per-
centage of CD31CD45CD24hiCD29hiSca1 mammary stem
cells was unaffected. Therefore, Fbxo30 mutation does not
affect the number of mammary stem cells (Figure 3B). Despite
their normal numbers, the size of the Fbxo30/ mammosphere
was markedly reduced (Figures 3C and 3D).
Taken together, the data in Figures 1, 2, and 3 reveal that,
while Fbxo30 is not required for mammary stem cell mainte-
nance, it is required for differentiation and/or expansion of
luminal progenitors into ductal and/or alveolar cells.
Fbxo30 Is the E3 Ligase of EG5
Fbxo30 is an orphan FBX with no known substrate. To fill in this
gap, we isolated the FLAG-tagged Fbxo30-associated proteins
by coimmunoprecipitation (coIP) with anti-FLAG antibodies.
The proteins eluted with free FLAG peptides were digested
with trypsin and analyzed by mass spectrometry. In addition to
those from Fbxo30, peptides from Skp1 and Cullin were promi-
nently represented, as expected. Interestingly, to our knowl-
edge, seven unique peptides from the bipolar kinesin motor pro-
tein EG5 were identified (Figure 4A). To confirm this interaction,
we probed anti-FLAG immunoprecipitates of either vector or
Fbxo30-FLAG-transfected 293T cells. As shown in Figure 4B,
anti-FLAG specifically co-precipitated EG5, Skp1, and Cul1.
Since there are no commercial antibodies that satisfactorily
immunoprecipitate FBXO30, we knocked in a 33 FLAG tag
immediately before the stop codon in the FBXO30 open reading
frame (Zhang et al., 2008) (Figure S2), and we used an anti-FLAG
mAb to determinewhether endogenous FBXO30 associates with
EG5. As shown in Figure 4C (left panel), anti-FLAG precipitated
FBXO30 and EG5 as well as polyubiquitinated proteins. Recipro-
cally, anti-EG5 specifically co-precipitated FBXO30 (Figure 4C,
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Figure 1. Defective Mammopoiesis in Fbxo30/ Mice
(A) Morphological defects of virgin Fbxo30/ mammary glands by whole-mount Carmine alum staining show reduced branching and atrophic large ducts. The
images are representative from three independent experiments, each of which involves three mice per group. Bar graphs depict ratios of length of lateral
branches to that of the large ducts. Length wasmeasured by Neurolucida Tracing software (MBF Bioscience). Data shown are means and SEM (p = 0.0005). Data
presented are summary data from one experiment involving three mice per group. One fat pad per mouse was analyzed. The data have been reproduced in
another independent experiment.
(B) Morphological defects of mammary glands in 12-day pregnant Fbxo30/ mice and WT littermates were visualized in whole-mount sections. Reduction in
mammary gland branching in pregnant Fbxo30/ female mice was determined as in (A), except that the mammary glands were isolated from day 12 of the first
pregnancy (p = 0.007). Data presented are summary data from one experiment involving three mice per group. One fat pad per mouse was analyzed. The data
have been reproduced in another independent experiment.
(C) Histology analysis of postpartum mammary gland reveals atrophy and lack of milk droplets in the Fbxo30/ female mammary glands. Samples collected at
day 2 postpartum were fixed in formalin and stained with H&E. Similar results were obtained in eight mice analyzed (three WT and five Fbxo30/ mice).
(D) Reduction of luminal epithelial cells in the Fbxo30/mammary gland. Formalin-fixedmammary gland tissue sectionswere stained with antibodies specific for
either cytokeratin 5 (CK5, basal myoepithelial cells) or cytokeratin 8 (CK8, luminal epithelial cells). The images in the upper panels are representative of four
independent experiments involving onemouse per group (scale bar, 20 mm). Data shown in the right panel are the ratios of K8+/K5+ cells. The error bar depicts the
SEM (n = 10 glands from one fatpad in each group). Data have been reproduced three times.
(E) Defective production ofmusin by luminal epithelial cells in Fbxo/mammary glands. As in (D), except that themammary sections were stainedwith antibodies
against CK14, SMA, and CK17, respectively, in conjunction with Muc1.right panel). These results confirmed the endogenous associa-
tion between EG5 and FBXO30. Moreover, inhibition of protea-
some increased EG5 in whole-cell lysate (Figure 4D). Using trun-
cationmutant of Eg5, we observed that Fbxo30 interacts with the
C-terminal region rather than the N-terminal and central parts of
Eg5. The binding sites likely reside between aa 812 and 1,052
(Figure 4E).
To confirm that Fbxo30 is the E3 ligase for EG5, we isolated
the Fbxo30 proteins from Fbxo30-FLAG transfectants and incu-
bated themwith Myc-tagged EG5 in the ubiquitinylation reaction
mixture containing an E1 ubiquitin-activating enzyme and an E2ubiquitin-conjugating enzyme. The extent of Eg5 ubiquitinylation
was determined by immunoblot with an anti-polyubiquitin anti-
body. As shown in Figure 4F (upper panel), incubation of EG5
with Fbxo30 in the presence of E1 and E2 resulted in robust
EG5 ubiquitinylation. After normalizing the amount of input pro-
tein, it was clear that EG5 ubiquitinylation did not require phos-
phorylation at either T927 or S1040, two phosphorylation sites
critical for the regulation of EG5 activity by CDK1 and Plk1-
NEK9-NEK6/7, respectively (Bertran et al., 2011; Blangy et al.,
1995; Rapley et al., 2008), as the relative amounts of polyubiqui-
tinated EG5 increased even though the amounts of EG5 wereCell Reports 15, 1111–1122, May 3, 2016 1113
Figure 2. Fbxo30 Deficiency Affects
Luminal versus Basal Lineage Choice
(A) Representative FACS profiles depicting selec-
tive reduction in luminal epithelial cells in the
mammary gland of the Fbxo30/ mice. The
markers and gating strategy used to define spe-
cific mammary gland cell types are indicated.
(B) Reduction in luminal/basal ratio among
Fbxo30/ mammary epithelial cells is shown.
(C) Number of recoverable luminal and basal
epithelial cells in mammary gland per mice. Data
shown are the numbers of epithelial cells with
either luminal or basal epithelial cell markers based
on FACS staining. Data shown in this figure are
representative data from an experiment involving
three mice in each group and have been repro-
duced three times.reduced. The mechanism of reduced accumulation of mutant
EG5 remains to be explained.
To identify potential ubiquitylation sites, we focused on a
patch of Lysine (K) between aa 891 and 913. As shown in Fig-
ure 4F (lower panel), while mutations of K891R and K899R sub-
stantially reduced polyubiqutylation of Eg5, other mutations had
minimal effect. These data further support ubiquitylation of Eg5
by Fbxo30, although they do not necessarily rule out additional
ubiquitylation sites on Eg5.
Eg5 activities are tightly regulated during the cell cycle by
phosphorylation (Bertran et al., 2011; Blangy et al., 1995; Rapley
et al., 2008). Since it is unclear whether Eg5 oscillates during
cell cycle, we arrested, at G0/1, S, and M phases, the HCT116
cells expressing a FLAG-tagged FBXO30 under the control of
its endogenous promoter. As shown in Figure 5A, EG5 levels
increased progressively from G0/1 phase, to S phase, to M
phase but reduced after the cells were released from the M
phase arrest. The peak EG5 level at M phase correlated with
the lowest FBXO30 level. To test whether Fbxo30 is responsible
for Eg5 accumulation, we arrested WT and Fbxo30/ mouse
embryonic fibroblasts (MEFs) at G1/G0, S, and M phases and
compared the Eg5 levels. As shown in Figure 5B, Eg5 levels
increased from G1 phase to S phase but peaked at the M phase
in the WT MEF. Targeted mutation of Fbxo30 accelerated the
increase of Eg5, as it peaked at S phase rather than M phase.
Since Fbxo30 was expressed at lower levels at M phase, it
was expected that deletion of this gene would not significantly1114 Cell Reports 15, 1111–1122, May 3, 2016affect EG5 levels (Figure 5B). The mecha-
nism for fluctuations of Fbxo30 during cell
cycles is currently unknown.
To determine whether Fbxo30 regu-
lates Eg5 in mammary gland epithelial
(MGE) cells, we arrested WT and
Fbxo30/ MGE cells at S phase, and
we determined Eg5 accumulation using
immunofluorescence in conjunction with
DAPI (Figure 5C). S-phase-synchronized
Fbxo30/ MGE cells exhibited markedly
increased overall Eg5 levels, as reflected
by huge increases of Eg5+ spots. Despitecomparable mRNA levels of the Kif11 gene, which encodes EG5
(Figure 5D), freshly isolatedMGE cells had substantially elevated
Eg5 protein, as revealed by western blot (Figure 5E). To deter-
mine whether Fbxo30 regulates Eg5 in vivo, we compared
the cellular levels of Eg5 in mammary glands from WT and
Fbxo30/mice by immunofluorescence. This analysis revealed
a marked increase in the cellular concentration of EG5 in
Fbxo30/ mammary gland (Figure 5F).
As an ATPase motor protein, Eg5 is targeted to the mitotic
spindle and centrosome and plays a critical role in mitosis (Mar-
din and Schiebel, 2012; Nigg and Stearns, 2011). Consistent with
the abnormal levels of Eg5 in Fbxo30/MGE cells (Figure 5), the
proliferation rate of Fbxo30/ MGE cells also was markedly
reduced over three passages (Figure 6A). To determine whether
the defective proliferation in MGE cells is attributable to
increased Eg5 activity, we used small hairpin RNA (shRNA) to
silence the Kif11 gene in the Fbxo30/ MGE cells (Figure 6B,
right panel). Consistent with a critical role for Eg5 in cell pro-
liferation (Bertran et al., 2011; Blangy et al., 1995; Rapley
et al., 2008), growth of WT MGE cells was inhibited by shRNA
specific for the Kif11 gene. In contrast, shRNA silencing of
Kif11 increased the proliferation of Fbxo30/ MGE cells (Fig-
ure 6B). Furthermore, Kif11 shRNA significantly increased the
size of mammospheres (Figure 6C).
Reintroduction of WT Fbxo30 to the mammary epithelial
cells through ectopic expression partially restored the mammo-
sphere formation (Figure 6D). While these data confirmed the
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Figure 3. Impact of Fbxo30 Deficiency on Number and Differentiation of Mammary Stem Cells
(A) Representative FACS profiles depicting WT and Fbxo30/ mammary epithelial cells. The stem cells were defined as CD29hiCD49fhiCD24hi Sca-1.
(B) Summary data on the percentage of mammary stem cells in WT and Fbxo30/ mammary gland. Data shown are means and SEM (n = 5 mice per group),
summarized from three independent experiments.
(C) Fbxo30/ stem cells have diminished production of progeny in mammosphere culture. Representative images depict the reduction in mammosphere size
(scale bar, 50 mm).
(D) Areas of the representative mammosphere. Each dot represents the area of an individual sphere, as calculated using Scion software. These data have been
reproduced three times.function of Fbxo30, they also suggested that ectopic expression
of Fbxo30 does not fully recapitulate the function of endoge-
nous alleles.
To determine whether increased EG5 is responsible for the
defective mammopoiesis during pregnancy, we treated day 6
pregnant Fbxo30/ mice with the Eg5 inhibitor monastrol
(Mayer et al., 1999), and we analyzed the mammary gland
morphology at day 12. As shown in Figures 6E and 6F, a short-
term treatment of the Fbxo30/ mice with monastrol substan-
tially rescued mammopoiesis, as revealed by the increased
branching and distance between the alveoli and the large ducts.
Therefore, elevated Eg5 activity is responsible for the defective
mammopoiesis of Fbxo30/ MGE cells in both virgin and preg-
nant mice.
Given the role of Eg5 in centrosome separation (Mardin et al.,
2011; Mardin and Schiebel, 2012), we evaluated the impact of
Fbxo30 mutation on mitosis. Based on DNA content, it was
clear that deletion of Fbxo30 caused G2/M arrest and poly-
ploidy (Figure 7A). To understand how Fbxo30 defects affect
genome instability and G2/M arrest, we analyzed Eg5 distribu-
tion and mitotic spindles in mitotic WT MGE cells. We foundthat Eg5 was targeted to bipolar mitotic spindles, with a higher
concentration at the two poles of the MGE cells. However, in
the Fbxo30/ MGE cells, Eg5 was targeted to multipolar spin-
dles or bipolar multiple spindles, resulting in abnormal separa-
tion of chromosomes (Figures 7B and 7C). This was due to
overactive Eg5, as the number of cells with abnormal spindles
was normalized by Eg5 inhibitor (Figure 7D). Consistent with
increased multipolar spindles, targeted mutation caused
centrosome amplification, as indicated by the percentage of
MGE cells with more than two centrosomes (Figure 7E). This
was mediated by increased Eg5, as the reduction of Eg5
through shRNA silencing of Kif11 attenuated the defects
(Figure 7F).
A critical issue is whether defective spindle formation can
be found to increase in the Fbxo30/ mammary glands. To
address this issue, we stained mammary gland with anti-
b-tubulin antibodies and DAPI and searched for cells with mitotic
spindle in mammary glands. Mitotic cells were readily observed
in the mammary glands from the Fbxo30/ mice but rarely in
those from WT mice, which is consistent with a G2/M arrest of
Fbxo30/ MGE cells in vivo. Remarkably, while the WT MGECell Reports 15, 1111–1122, May 3, 2016 1115
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Figure 4. Fbxo30 Is an E3 Ligase for EG5
(A) Identification of EG5 and other SCF components in a complex bymass spectrometry analysis. 293T cells were transfected with cDNA encoding FLAG-tagged
Fbxo30 or an unrelated protein (Laforin). FLAG-tagged proteins were purified by immunoprecipitating with anti-FLAG. Immunoprecipitated proteins were eluted
with FLAG peptide. The Fbxo30-associated proteins were concentrated by SDS-PAGE. The gel slices of 1 cm were submitted to Taplin Biological Mass
Spectrometry Facility at the Harvard Medical School (https://taplin.med.harvard.edu) for using the microcapillary liquid chromatography-tandem mass spec-
trometry (LC-MS/MS) technique. The numbers of unique, to our knowledge, peptides associated with Fbxo30 are listed, while peptides shared with Laforin are
excluded.
(B) Confirmation of EG5-SCF complex by coIP. cDNA encoding FLAG-tagged Fbxo30was transfected into 293T cells. After immunoprecipitation with anti-FLAG,
the precipitates were probed for EG5, SKP1, and CUL1 by their specific antibodies.
(C) Association between endogenous EG5 and Fbxo30. The endogenous FBXO30 was tagged with a 33 FLAG epitope by homologous knockin (see Figure S2).
The left panel shows that anti-FLAG-Fbxo30 co-precipitated endogenous EG5; the right panel shows co-precipitation of endogenous FBXO30 by anti-EG5.
(D) Impact of proteasome inhibitor MG132 andMphase arrest on endogenous EG5 levels: effect of ectopically expressed Fbxo30. After 24 hr of being transfected
with empty vector or Fbxo30-FLAG-expressing vector, the 293T cells were treated with 2.5 mMMG132 or 50 nM nocodazole for an additional 6 hr before being
lysed for western blot. Note that, in vector control, EG5 levels increased after MG132 treatment and that EG5 overexpression decreased EG5 at M phase.
(E) Eg5 C-terminal region interacts with Fbxo30. As in (B), except either full-length or indicated truncation mutants were used and that Eg5 was detected by anti-
Myc antibody. The left panel shows the immunoprecipitation-western blot data, while the right panel depicts the expression levels in the lysates.
(F) In vitro ubiquitinylation of Eg5 by Fbxo30. Data in upper panels show phosphorylation-independent ubiquitylation, while those in the lower panels show
selectivity of ubiquitylation. Fbxo30-FLAG protein was purified from HEK293 cells transfected with FLAG-tagged Fbxo30 and incubated with bead-bound EG5
isolated from EG5-Myc-transfected cells and with a ubiquitinylation system containing E1, E2, and proteasomal components. After removing the unbound
components by re-immunoprecipitating Eg5 with a c-Myc antibody, the extent of Eg5 ubiquitinylation was determined by immunoblot with an anti-polyubiquitin
antibody (top), while the amount of EG5 was determined with an anti-Myc antibody (bottom). WT Eg5 was used in the upper panel, while the K > Rmutants were
compared with WT Eg5 in the lower panel. Data in (B)–(E) are representative images and have been repeated two times.
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Figure 5. FBXO30 Regulates EG5 Oscillation during Cell Cycle
(A) Increased EG5 protein levels at mitosis correlate with reduced Fbxo30. HCT116 cells with Fbxo30-3x-FLAG knockin alleles were arrested at G0/1 phase with
serum-free medium, early S phase with 1 mg/ml aphidicolin, or M phase with 50 ng/ml nocodazole. All treatments were performed for 16 hr. The lysates were
analyzed for the endogenous levels of EG5 and Fbxo30 by western blot. GSK3 levels were used as a loading control. Data shown have been reproduced three
times.
(B) Fbxo30 deletion greatly increases Eg5 levels at S andMphases of the Fbxo30/MEFs.WT and Fbxo30/MEFswere arrested for 16 hr in serum-freemedia,
1 mg/ml aphidicolin, or 50 ng/ml nocodazole. The lysates were analyzed for the endogenous levels of EG5 by western blot. b-actin levels were used as a loading
control. The relative amounts of EG5 protein are provided underneath each lane. The numbers indicate the ratio of signals from anti-EG5 over anti-b-actin. Data
shown have been reproduced three times.
(C) Elevated Eg5 levels in Fbxo30/ MGE cells. WT and Fbxo30/ MGE cells were arrested at S phase with 1 mg/ml aphidicolin for 16 hr. Images shown are
representative of those obtained from three independent experiments.
(D) Normal expression of the Kif11(Eg5-encoding) gene in Fbxo30/ mammary glands. RNA isolated from single-cell suspension of WT and Fbxo30/
mammary glands was analyzed for expression of Fbxo30 and Kif11. While deletion of Fbxo30 abolished expression of Fbxo30, it had no effect on the Kif11
transcript, as determined by real-time PCR.
(E) Western blot data using lysate MGE cells (n = 3). The images of the western blot are shown in the top panel. The relative amounts of Eg5 protein are provided
underneath each lane. The numbers indicate the ratio of signals from anti-Eg5 over anti-Gapdh. These data have been reproduced twice.
(F) Eg5 staining in WT and Fbxo30/mammary glands as determined by immunofluorescence. The nuclei are visualized by the DNA dye DAPI. Data shown are
representative images from three experiments, each involving one fatpad from one mouse per group.cells had normal bipolar mitotic spindle, essentially all of the
mitotic cells in the Fbxo30/ mammary glands contained
abnormal spindles, including those with mono- or multipolar
spindles with abnormal donut-type chromatin (Figure 7G; Fig-
ure S3). The increase of cells with either mono- or multipolar
spindles in mammary glands phenocopied what was observed
in MEFs cultured from transgenic mice that overexpressed Eg5
(Castillo et al., 2007).DISCUSSION
Taken together, we have demonstrated that Fbxo30 is an
E3 ligase that specifically ubiquitinylates and regulates Eg5
levels in mammary epithelial cells and MEFs. The Fbxo30-
Eg5 pathway controls centrosome homeostasis and genome
stability. Since cells with abnormal mitotic spindles undergo
apoptosis (Ganem et al., 2009), the defective cell growth andCell Reports 15, 1111–1122, May 3, 2016 1117
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Figure 6. Fbxo30 Regulates Cell Proliferation and Mammopoiesis through EG5
(A) Fbxo30 is required for propagation of mammary epithelial cells in vitro. Data shown are the number of WT and Fbxo30/ MGE cells over three passages.
(B) The shRNA silencing of Kif11 reduces proliferation of WT MGE cells, but modestly enhances proliferation of Fbxo30/ MGE cells. Freshly isolated WT or
Fbxo30/ MGE cells were transduced with lentiviral vectors with either scrambled or Kif11 shRNA for 24 hr. Equal numbers of transduced cells were re-plated
and counted over three passages. The efficiency of Kif11 shRNA silencing is shown in the right panel.
(C) The shRNA silencing of Kif11 in Fbxo30/MGE cells increases the size of mammospheres. Transduced primary MGE cells were cultured for mammosphere
assay. Data shown are the surface area of individual spheres from the two groups. The p value was calculated by Student’s t test. Data shown in (A)–(C) are
representative of three independent cultures.
(D) Ectopic expression of Fbxo30 partially restores sizes of Fbxo30/mammospheres. Fbxo30/ epithelial cells were transduced with lentiviral vector alone or
those with Fbxo30 cDNA prior to culture. These data have been reproduced three times.
(E and F) Restoration of mammopoiesis of pregnant Fbxo30/mice bymonastrol, including increased secondary branching and reduced alveoli associated with
the large ducts. Day 6 pregnant Fbxo30/mice received three injections of either vehicle control or monastrol (5mg/kg, every other day, intraperitoneal injection)
over a 6-day period. Mammary glands were harvested on day 12 of pregnancy and used for whole-mount sections.
(E) Representative images of whole-mount sections from one of three mice in each group, one fatpad analyzed per mouse. This experiment has been repeated
two times. A whole-mount section of WT mammary gland is included for comparison.
(F) Summary data of the ratio of the length of lateral branches to that of the large ducts, asmeasured by Neurolucida Tracing software. Data shown are from one of
two independent experiments (n = 3 mice per group, one fat pad per mouse is analyzed). Error bars are SEM.genome instability observed in the Fbxo30/ cells are intrinsi-
cally connected.
Previous studies have demonstrated that EG5 targeting to the
spindle pole is regulated by phosphorylation at sites T927 and
S1040 by Cdk1 and Plk1-Ned6, respectively (Bertran et al.,
2011;Blangyet al., 1995;Rapley et al., 2008), and their phosphor-
ylation is critical for correct formation of mitotic spindle. Our data
demonstrate that phosphorylation of neither site is required for
EG5 ubiquitinylation. Thus, Eg5 is subject to at least two layers1118 Cell Reports 15, 1111–1122, May 3, 2016of regulation: Cdk1- and Plk1-Nek9-Nek6/7-mediated phos-
phorylation, which regulates localization but not Eg5 levels, and
the Fbxo30-mediated ubiquitinylation, which controls Eg5 levels.
A phospho-peptide analysis revealed that endogenous Eg5 was
phosphorylated only at the T927 and S1040 sites in vivo (Rapley
et al., 2008), and since mutation of neither site abolished Eg5
ubiquitinylation, it is likely that Fbxo30-mediated Eg5 degrada-
tion occurs either by a phosphorylation-independent pathway,
which would be similar to the Fbxo1-CP110 and Fbx011-BCL6
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Figure 7. Fbxo30 Deletion Causes Chromosomal Instability and Spindle Defects In Vivo and In Vitro
(A) DNA content analysis based on propidium iodide staining of ethanol-fixed MGE cells after two passages in vitro. Representative FACS profiles are shown on
top and the summary data involving three mouse samples per group are shown on the bottom. Note a major increase in cells with >4N in DNA content.
(B) Deletion of Fbxo30 causes formation of multipolar mitotic spindles. WT (upper panels) and Fbxo30/ (lower panels) MGE cells were stained for EG5, tubulin,
and DNA.
(C) Summary data for three different cultures (n = 3) are shown.
(D) Monastrol treatment reduces the percentage of MGE cells with abnormal spindles. As in (C), except that the MGE cells prepared from Fbxo30/ mice were
treated with either vehicle control or monastrol (30 nM) for 48 hr prior to staining.
(E) Fbxo30 deletion causes abnormal centrosome amplification. The images on the left depict g-tubulin distribution in aWT and three Fbxo30/MGE cells, while
the right panel shows the mean and SEM of the percentage of cells with more than two centrosomes (n = 15) and has been repeated three times.
(F) The shRNA silencing of theKif11 gene restores centrosome homeostasis in Fbxo30/MGE cells. Fbxo30/MGE cells were cultured in the presence of either
vehicle or a low dose of monastrol (30 nM) for 48 hr. The centrosome number was determined by g-tubulin staining. Data shown are means and SEM of the
percentage of cells with more than two centrosomes (n = 10) and have been repeated three times.
(G) Accumulation ofmultipolar spindlemitotic cells in the Fbxo30/mammary glands, as revealed by staining with anti-b-tubulinmAb andDAPI staining of frozen
mammary gland sections. The top panels show a cell with a normal bipoplar spindle in WTmammary gland; the lower panels show a cell in Fbxo30/mammary
gland with multipolar mitotic spindle and abnormal distribution of chromatin. Cells with mitotic spindle are difficult to find in vivo. Only one such cell was found in
five slides prepared from five virgin mice, while more than 50 cells withmitotic spindle were found in two of the five slides from the five virgin Fbx30/mice. None
of the mitotic spindles have normal morphology. Seven such cells are shown in Figure S3.interactions (D’Angiolella et al., 2010; Duan et al., 2012), or by
phosphorylation at other sites. Two recent studies demonstrated
that the APC/C-CDH1 complex also caused ubiquitinylation of
EG5 (Drosopoulos et al., 2014; Eguren et al., 2014). Given the
specific activation of the APC/C-CDH1 during mitosis, and giventhe relatively low expression and small effect of Fbxo30 defi-
ciency on EG5 levels at M phase, we suggest that Fbxo30 and
APC/C-CDH1 may function at different phases of the cell cycle
in regulating EG5 levels, although the possibility that the different
E3 may function in different cell types cannot be ruled out.Cell Reports 15, 1111–1122, May 3, 2016 1119
The mitotic spindle defects observed in the Fbxo30/ mam-
mary epithelial cells is a direct consequence of Eg5 overexpres-
sion, as it can be normalized by shRNA silencing of EG5. More-
over, since normalization of Eg5 activity by monastrol and/or
Kif11 shRNA rescued defects in centrosome homeostasis,
cellular proliferation, mammosphere formation, and mammo-
poiesis, the defective regulation of EG5 levels is likely the root
cause of genome instability and defective mammopoiesis in
the Fbxo30/ mice.
Apart from a critical function of Fbxo30 in mammopoiesis
described herein, a recent report suggested that Fbxo30 was
negatively regulated by the BMP-signaling pathway and contrib-
uted to loss of muscle mass caused by defective BMP signaling
(Sartori et al., 2013). However, the Fbxo30 substrate involved in
the regulation of muscle mass was not identified. Paradoxically,
mice lacking Fbxo30 have normal development, fertility, and life-
span. Since the developmental pathway for mammary gland is
similar to that of T cell differentiation (Watson and Khaled, 2008),
we investigated the possible role of EG5 in the development and
accumulation of T cells in the thymus and spleen. We found that
cellular compositions of spleen and thymus were largely unaf-
fected by Fbxo30 deletion (Figures S4 and S5). As a potential
explanation for lackof functionof Fbxo30 in spleencells,we found
that expression of Fbxo30 among spleen cells was considerably
lower than in the mammary epithelial cells (Figure S6A). Corre-
spondingly, the levels of EG5 were largely unaffected by deletion
of theFbxo30gene (FigureS6B).With recent identificationofAPC/
C-CDH1as anE3 ligase for EG5 (Drosopoulos et al., 2014; Eguren
et al., 2014), it is possible that this or anotherE3mayserve to regu-
late EG5 depending on the cell types studied.
Accumulating data have demonstrated that some of the most
critical regulators of centrosome homeostasis, including Plk4,
SAS6, and Cp110, are regulated by SCF-type E3 ligase (Silver-
man et al., 2012). Our data demonstrate that Eg5 abundance,
as well as its oscillation during cell cycle, also is regulated by
an E3 ligase. It is of note that Eg5 levels frequently are elevated
in human cancer and that such elevation correlates with poor
prognosis (Ding et al., 2011; Saijo et al., 2006). Since transgenic
expression of Eg5 leads to abnormal centrosome homeostasis,
genetic instability, and cancer development (Castillo et al.,
2007), it would be of interest to test whether Fbxo30 defects
may contribute to Eg5 elevation in human cancer.
EXPERIMENTAL PROCEDURES
Generation of Fbxo30/ Mice
The mice were generated by inGenious Targeting Laboratories through a
research contract. The constructs generated are diagrammed in Figure S1.
Briefly, a 13.2-kb region used to construct the targeting vector was first subcl-
oned from a positively identified B6 BAC clone using a homologous recombi-
nation-based technique. The region was designed such that the short homol-
ogy arm (SA) extended 1.9 kb to the 50 Neo cassette. The long homology arm
(LA) started at the 50 end of the GFP cassette and was 7.8 kb. The GFP/Neo
cassette was inserted 3 bp before the ATG of exon 1 and replaced 3.5 kb
of the gene sequence. The targeting vector was confirmed by restriction anal-
ysis after eachmodification step and by sequencing using primers designed to
read from the LacZ/Neo cassette into the 50 end of the SA (N1) and the 30 end of
the LA (GFP1) or from primers that anneal to the vector sequence, P6 and T7,
and read into the 50 and 30 ends of the BAC subclone. The BACwas subcloned
into a2.4-kb backbone vector containing an ampicillin selection cassette for1120 Cell Reports 15, 1111–1122, May 3, 2016retransformation of the construct prior to electroporation. The total size of the
targeting construct (including vector backbone and GFP/Neo cassette) was
14.7 kb. The targeting vector (10 mg) was linearized by AscI and then trans-
fected by electroporation of iTL C57 BL/6 ESCs. After selection in G418, sur-
viving clones were expanded for PCR analysis to identify recombinant ESC
clones. Primers, A1was designed downstream (30 ) to the SA outside the region
used to generate the targeting construct. ESCs with a targeted locus were in-
jected into albino C57BL/6 blastocysts to generate chimeric mice. Chimera
were identified by coat color and used to generate mice with germline trans-
mission of the targeted Fbxo30/ locus.
Generation of HCT116 Cell Line with FLAG-Tagged Endogenous
Fbxo30
The vector construction and knockin by homologous recombination were
based on a previous report (Zhang et al., 2008). Briefly, the targeting vector
was constructed by PCR using genomic DNA as the template for the homolo-
gous left arm. Homologous recombination was screened by PCR with primers
derived from the neomycin resistance gene and the upstream region of the left
homologous arm. Two clones were identified from two 96-well plates of G418-
resistant clones. The neomycin resistance gene was excised by Cre recom-
binase. The following primers were used: 3FLAG KI FBXO30 left arm F,
GGGAAAG/ideoxyU/atttgtaaagatgaggggcttg; 3FLAG KI FBXO30 left arm
R, GGAGACA/ideoxyU/GcAAGTACAGGTTTTAAAACTGAGCG; 3FLAG KI
FBXO30 right arm F, GGTCCCA/ideoxyU/AAGTTGTAATATTACTAGCACATA;
3FLAG KI FBXO30 right arm R, GGCATAG/ideoxyU/ ACTTTCTTGGTGG
TGAAGCCTA; 3FLAG KI FBXO30 left screening F; tctaggtctgtcctgctctgc;
3FLAG KI FBXO30 right screening R, tttttaagcagaccacatcagg; 3FLAG KI
FBXO30 cre F, GAAGGACGTTCACTACGCTCA; and 3FLAG KI FBXO30 Cre
R, TTCCAAAAATTTCACACATTTCA.
Immunofluorescence
After deparaffinization and rehydration of slides with Xylene and ethanol, the
mammary gland sections from Fbxo30 knockout and WT mice were treated
with 10 mM sodium citrate buffer (pH 6.0). The sections were permeabilized
with 0.3% Triton X-100 in 10 mM Tris-HCl buffer for 30 min. After blocking
with 2% BSA for 60 min, sections were incubated with primary antibody
diluted in 10 mM Tris-HCl buffer containing 2% BSA at 4C overnight, with
subsequent staining with secondary antibody in BSA-Tris-HCl buffer at room
temperature for 2–4 hr. The nuclei were stained with DAPI. Slides were
mounted with Prolong Antifade mounting buffer (Invitrogen). Antibodies for
EG5 (NB500-181, Novus), b-tubulin (F2043, Sigma), g-tubulin (T5326, Sigma),
Keratin 5 (AF138, Covance), Keratin 8 (TROMA-I, Developmental Studies Hy-
bridoma Bank [DSHB]), Keratin K14 (ab7800, Abcam), Keratin K17 (ab53707,
Abcam), and aSMA (ab5694, Abcam) were used for immunofluorescence.
Transplantation
Female mice (3 weeks old) were anesthetized with Ketamine and Xylazine. An
inverted Y incision was made from the midline point between the fourth set of
nipples and ending at a point between the fourth and fifth sets. The fourth and
fifth fat pads on each side were exposed using forceps to separate the skin
from the body cavity. Half of the fourthmammary fad pad from the fourth nipple
to the lymph node was removed using scissors to clear the mammary epithe-
lium, and 1 3 106 mammary epithelial cells suspended in 30 ml Hank’s
balanced salt solution plus 2% fetal bovine serum (FBS) were injected into
the mammary epithelium-cleared fat pads. After cell transplantation, the inci-
sion was sutured with 9-mm autoclips, and the mice were placed in a clean
cage and were monitored for a short period of time. Staples were removed
2 weeks after surgery.
Isolation and Culture of Mammary Gland Epithelia
Mammary glands were minced with razor blades on a sterile surface and then
transferred to a tube containing dissociation solution (EpiCult-B medium with
collagenase and Hyaluronidase, STEMCELL Technologies) and incubated for
7 hr at 37C with occasional pipetting and vortexing. After dissociation, the
cells were collected by centrifugation at 350 3 g. Pre-warmed Trypsin-EDTA
(1–5 ml) was added to the partially dissociated tissue and mixed by pipetting
for 1 to 3 min. Cold Hank’s balanced salt solution (10 ml) supplemented with
2%FBSwas added to stop the digestion, and the cells were again collected by
centrifugation at 3503 g for 5min. To dissociate the clumps, 2 ml pre-warmed
5mg/ml Dispase (07913, STEMCELL Technologies) and 200 ml 1 mg/ml DNase
I (07900, STEMCELL Technologies) were added to the pellet and then pipetted
for 1 min with a P1000 micropipetor to further dissociate cell clumps. The cell
suspension was then diluted with an additional 10 ml cold Hank’s balanced
salt solution supplemented with 2% FBS and filtered through a 40-mm cell
strainer into a new 50-ml centrifuge tube. Cells were collected after centrifuga-
tion and red blood cells were lysed as needed.
Flow Cytometry
The isolated cells from the mammary glands of WT and Fbxo30/ mice were
stained with fluorochrome-conjugated anti-CD31, CD45.2, CD61, CD24,
CD49f, CD29, Sca-1, and CD133 monoclonal antibodies (eBioscience). The
stained cells were analyzed by a fluorescence-activated cell analyzer (LSR II).
Mammosphere Assay
The isolated cells from the mammary glands of either WT or Fbxo30/ mice
were suspended in the EpiCult-B (STEMCELL Technologies) and seeded in ul-
tra-low attachment six-well plates (Corning). The cells were cultured for 7 days
and the formed mammospheres were photographed. The surface areas of the
mammospheres were measured based on analysis of the images using Scion
image software.
Whole-Mount Staining
Whole-mount preparations of mammary glands were performed according to
the protocol reported by Mueller et al. (2002). Briefly, inguinal number 4 mam-
mary glands were dissected, spread on glass slides, and fixed overnight in Car-
noy’s fixative. The next day, the tissues were hydrated and then stained in
carmine-aluminum stain overnight. The tissues were dehydrated, cleared in
xylene, andmountedbetween twoglassslidesusingPermountmountingmedia.
shRNA Silencing
The lentiviral vector pLenti6/V5-TOPO, obtained from Invitrogen, wasmodified
by replacing the CMV promoter with a U6 promoter to drive an shRNA-ex-
pressing cassette and inserting a pGK-driven EGFP cassette and a blastici-
din-resistant cassette. The sequence used to silence Kif11 was 50-TGCAGGT
CAGATTTACACT-30 (sh1) and TATTGTCTTCAGGTCTTCA (sh2). TheMGE cell
cultures were infected with either scrambled shRNA control lentivirus or lenti-
virus encoding Kif11-shRNA for 24 hr. After recovery for an additional 48 hr, the
cultures were used for assays.
In Vitro Ubiquitinylation Assay
All the reagents used for the in vitro ubiquitinylation assay were purchased
from Boston Biochem (K930). Ubiquitinylation was performed according to
standard protocols provided by the supplier, with modifications. In brief,
HEK293 cells were transfected with Eg5-Myc or its phosphorylation site mu-
tants. Anti-Myc immunoprecipitate beads were mixed with components of
the ubiquitinylation system in the presence or absence of Fbxo30 proteins,
which were eluted using FLAG peptide from anti-FLAG immunoprecipitates
of transfected HEK293 cells using FLAG peptide. After 2 hr of incubation at
37C, the beads were washed with a 1% Triton X-100 Tris-HCl buffer, resus-
pended with a 2% SDS Tris-HCl buffer, and re-immunoprecipitated with an
anti-Myc antibody after a 10-fold dilution with a 1% Triton X-100 Tris-HCl
buffer. The final immunoprecipitates were resuspended in SDS loading buffer,
heated for 3 min at 90C, and resolved by 10% SDS-PAGE.
Immunoprecipitation and Western Blot
Cells or tissues were lysed with a 1% Triton X-100 buffer containing 20 mM
Tris-HCl (pH 7.4), 150 mM NaCl, 40 mM NaF, 2 mM DTT, and a protease
and phosphatase inhibitor cocktail (Sigma). The cleared lysates were immuno-
precipitated with protein G beads and antibody at 4C with overnight shaking.
After washing with the lysis buffer for three times, the beads were treated with
SDS loading buffer and the eluted proteins were analyzed by western blot. The
EG5 antibodies used for western blot and immunoprecipitation were a rabbit
antibody (ab61199, Abcam) and a mouse antibody (NB100-78467, Novus
Biologicals), respectively.Measurement of Duct and Branch Lengths
The ratio of branch over duct length was measured using a method developed
for measuring neurite and axon lengths (Kim et al., 2013; Sterne et al., 2015).
The Neurolucida software (MBF Bioscience) was used to trace and measure
the length of duct and that of the branches in a double-blind fashion. Total
lengths of either ducts or branches in all areas captured in low-power images
(see Figures 1A, 1B, and 6D as examples) were integrated to calculate the
branch over duct ratios.
Statistics
Student’s t test was used to determine statistical significance between two
groups of samples.
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